MBE Wealth Management’s Exact Sciences EXAS Stock Holding History

MBE Wealth Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-265	Closed	-$15K	–	193
2020 Q1	$15K	Buy	+265	New	+$21.5K	0.01%	244

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

MBE Wealth Management's EXAS Position: Q2 2020 in Review

MBE Wealth Management sold out of Exact Sciences (EXAS) in Q2 2020, closing a stake of 265 shares — an estimated $15K sold.

MBE Wealth Management first reported a position in EXAS in Q1 2020 and held it in 1 quarter. The position peaked at $15K in Q1 2020. 513 funds tracked by Wall St. Rank hold EXAS as of Q2 2020.

MBE Wealth Management reported no remaining Exact Sciences position as of Q2 2020 after selling out during the quarter.
MBE Wealth Management sold 265 Exact Sciences shares in Q2 2020, an estimated $15K.
MBE Wealth Management first reported a position in Exact Sciences in Q1 2020 and held it in 1 quarter.
MBE Wealth Management's Exact Sciences position peaked at $15K in Q1 2020.
513 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2020.

Based on MBE Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.